Skip to main content
EASY BIO, Inc. logo

EASY BIO, Inc. — Investor Relations & Filings

Ticker · 353810 ISIN · KR7353810005 LEI · 988400OOAWY9V3ZW5E12 KO Manufacturing
Open in API
Filings indexed 174 across all filing types
Latest filing 2022-03-31 Declaration of Voting R…
Country KR South Korea
Listing KO 353810

About EASY BIO, Inc.

https://www.easybio.co.kr/en2021/main/

EASY BIO, Inc. is an animal nutrition company that develops, manufactures, and markets animal feed products and additives. The company specializes in solutions for the livestock industry, with a notable focus on piglet feed. It operates across the food value chain, managing feed mills and owning pork and poultry production facilities. Through its subsidiaries, EASY BIO also provides advanced services such as livestock diagnostics, integrating biotechnology into its core animal health and nutrition offerings. The company aims to establish a new standard in the animal industry by providing comprehensive solutions that support animal health and productivity.

Recent filings

Filing Released Lang Actions
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official report of the results of a General Meeting of Shareholders (AGM). It details the approval of financial statements, dividend resolutions, and the election of directors. This falls under the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it provides the official outcome of shareholder votes.
2022-03-31 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a regulatory filing titled '사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고' (Report on the Appointment, Dismissal, or Resignation of Outside Directors). This document specifically details changes to the company's board of directors, which falls under the category of Board/Management Information (MANG).
2022-03-31 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal regulatory filing titled 'Audit Report Submission' (감사보고서 제출) from the company Eezy Bio. It provides the auditor's opinion (unqualified/proper), key financial data (assets, liabilities, equity, revenue, profit), and details regarding the audit firm (Hanul Accounting Corp). While it contains financial data, it is a specific regulatory disclosure required by the Korean stock exchange (DART system) to announce the receipt and submission of the audit report, rather than the full Annual Report (10-K) itself. Therefore, it is classified as an Audit Report / Information document. FY 2021
2022-03-23 Korean
사업보고서 (2021.12)
Interim / Quarterly Report Classification · 95% confidence The document is a 'Consolidated Audit Report' (연결감사보고서) for E-Z Bio Co., Ltd. It includes the independent auditor's report, consolidated financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes to the financial statements for the fiscal year ending December 31, 2021. Since it contains comprehensive financial statements and analysis for a specific period (not a full 10-K annual report, but a standalone audit report containing financial data), it is classified as an Interim/Quarterly Report (IR) in the context of financial reporting standards where standalone audit reports of this nature are categorized under financial reporting. FY 2021
2022-03-23 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (EASY BIO) regarding a significant change in revenue or profit structure (30% or more). This is a standard disclosure requirement in the Korean stock market (KRX) for material financial changes. Since it is a specific regulatory disclosure of financial performance metrics rather than a full annual report or a simple announcement of a report, it falls under the 'Regulatory Filings' category. FY 2021
2022-03-16 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 100% confidence The document is a formal announcement from Eezy Bio regarding a decision on cash dividends. It specifies the dividend amount per share, the dividend yield, the total dividend amount, the record date, and the date of the upcoming shareholder meeting for approval. This aligns perfectly with the definition of a 'Notice of Dividend Amount' (DIV).
2022-03-16 Korean

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.